Callan JMB Inc. (CJMB) Price to Earnings Ratio

Callan JMB Inc (CJMB) ensures organic expansion through direct B2B supplies of surgical equipment, focusing on niche dominance without mergers. Historical price action allows for tracking of this sector, where the indicator stands at -0.20. The business is currently in its formative stage, where licensing costs exceed revenue, creating an FCF deficit. Meanwhile, cash flows are gradually strengthening thanks to long-term agreements with clinics.

Callan JMB (CJMB) - P/E Multiple from 02/06/2025 to 11/10/2026

Analytical breakdowns for Callan JMB Inc

- price and consensus price forecast:
Stock Price Callan JMB Corp|CJMB - Price Target Chart
- market capitalization details:
Market Value Callan JMB Inc|CJMB - Real Price to Acquire Entire Company
- book capitalization information:
Accounting Value of a Share Callan JMB|CJMB - Book Capitalization|Market Capitalization to Book Value callanjmb.com|CJMB - Aggregate Company Assets
- debt obligations and liquidity statistics:
Debt to Equity Ratio Callan JMB Inc|CJMB - Long-Term Debt to Equity|Short-Term Debt to Capital Coefficient Callan JMB Corp|CJMB - Company Total Debt|Debt to Book Capital Callan JMB Inc|CJMB - Company Long-Term Debt|Company Short-Term Loans and Borrowings Callan JMB|Quick Ratio callanjmb.com
- earnings and valuation multiples indicators:
CJMB - Company Net Income|Future Profit Callan JMB Inc|CJMB - P/E Multiple|Projected Price to Earnings Ratio Callan JMB Corp|CJMB - Price/Earnings to Growth Ratio|Enterprise Value to Operating Income Before Depreciation Callan JMB Inc|CJMB - Operating profit before deduction of amortization|Earnings per share for the last four quarters Callan JMB|CJMB - Earnings per share for the last twelve months|Year-over-year net earnings per share change for the last twelve months callanjmb.com|CJMB - Earnings growth in current year|Expected earnings per share growth for next year Callan JMB Inc
General company analysis:callanjmb.com, CJMB

Investors use this ratio to determine the degree of an asset's overvaluation relative to its earnings. The metric is calculated as the ratio of the share's market value to its earnings per share. By analyzing the forward P/E of the company, one can estimate the investment payback period. The revenue stability of Callan JMB Inc. (CJMB) is supported by long-term contracts with clinics. Expert medical equipment services ensure the resilience of fundamental indicators.

Analysis of competing companies

P/E Multiple intuitive.com|Price to Earnings Ratio Danaher (DHR)|Price to Earnings Ratio BDX (BD)|STERIS Corporation - Price to Earnings Ratio|Company Value to Net Income WST|Baxter International - P/E Multiple|Business Payback Period masimo.com MASI|Stevanato Group (STVN) - Price to Earnings Ratio|Price to Earnings Multiple TFX|Price to Earnings Ratio Merit Medical Systems Inc|Nobel Biocare (NVST) - Business Payback Period|Price to Earnings Ratio ICUI (ICU Medical, Inc.)|Market Price to Net Income Ratio XRAY|Price to Earnings Ratio LeMaitre Vascular LMAT|Company Value to Net Income ATRC|STAA: Price to Earnings Ratio|NAGE - P/E Multiple|ZimVie Inc. (ZIMV) - Price to Earnings Ratio|Price to Earnings Ratio angiodynamics.com|CERS (Cerus) - P/E Multiple|Market Cap to Earnings Alpha Teknova TKNO|Price to Earnings Ratio Monogram Technologies Inc (MGRM)|sharpstechnology.com - Price to Earnings Multiple|InfuSystem Holdings, Inc. - Price to Earnings Ratio|Market Price to Net Income Ratio UTMD (utahmed.com)|KRMD - Price to Earnings Ratio|Business Payback Period Nyxoah SA NYXH|MBOT: P/E Multiple|Price to Earnings Ratio Pro-Dex Inc.|ZTEK (Zentek Ltd.) - P/E Multiple|P/E Multiple elutia.com|Price to Earnings Ratio Milestone Scientific Inc. (MLSS)|Price to Earnings Ratio NXGL (NEXGEL Inc.)|Price to Earnings Ratio Retractable Technologies, Inc. RVP|harvardbioscience.com - Price to Earnings Ratio|Femasys Inc. - P/E Multiple|MHUA - P/E Multiple|predictive-oncology.com (POAI) - Price to Earnings Ratio|Price to Earnings Multiple ATRI|Price to Earnings Ratio NURO